Bali Pharma develops & commercializes pharmaceuticals to increase cancer patient survival and quality of life by reducing cancer therapy-induced toxicities which increases safety and effectiveness of the primary treatment. Bali re-purposes patented compounds as FDA-approved oncology drugs for toxic damage to nerve, intestinal and immune cells resulting in treatment discontinuation, patient distress, and FDA approval delays for newer therapies.